References
- Bécouarn Y., Brunet T., Barbe-Gaston C. Fluorouracil, doxorubicin, cisplatin and altratamine in the treatment of metastatic carcinoma of unknown primary. European Journal of Cancer and Clinic Oncology 1989; 25: 861–861
- Blanco-Prieto M. J., Delie F., Fattal E., Tartar A., Puisieux F., Gulik A., Coureurm P. Characterization of V3BRU peptide-loaded small PLGA microspheres prepared by a (w1/o) w2 emulsion solvent evaporation method. International Journal of Pharmaceutics 1994; 111: 137–145
- Boisdron-Celle M., Menei P., Benoit J. P. Preparation and characterization of 5-fluorouracil loaded microparticles as biodegradable anticancer drug carriers. Journal of Pharmacy and Pharmacology 1995; 47: 108–114
- Cai J., Zhu K. J. Preparation, characterization and biodegradable characterization of poly (D, L-lactide-co-1,3-trimethylene carbonate). Polymer international 1997; 42: 373–379
- Cai J., Zhu K. J., Yang S. L. Surface biodegradable copolymers — poly (D, L-lactide-co-1-methyl-1,3-trimethylene carbonate) and poly (D, L-lactide-co-2,2-dimethyl-1,3-trimethylene carbonate): preparation, characterization and biodegradation characteristics in vivo. Polymer 1998; 39: 4409–4415
- Fujii M., Kiura K., Okabe K., Toki H. Intrapleural cancer with carcinomatous pleuritis. Japanese Journal of Cancer Chemotherapy 1986; 13: 3203–3206
- Hagiwara A., Takahashi T., Sawai K., Sakakura C., Tsujimoto H., Imanishi T., Ohgaki M., Yamazaki J., Muranishi S., Yamamoto A., Fujita T. Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals. British Journal of Cancer 1996; 74: 1392–1396
- Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences 1963; 52: 1145–1149
- Hussain M., Beale G., Hughes M., Akhtar S. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microspheres formulations for potential combination therapy in cancer. International Journal of Pharmaceutics 2002; 234: 129–138
- Ike O., Shimizu Y., Ikada Y., Watanabe S., Natsume T., Wada R., Hyon S.-H., Hitonic S. Biodegradation and antitumor effect of adriamycin-containing poly (L-lactic acid) microspheres. Biomaterials 1991; 12: 757–762
- Ike O., Shimizu Y., Wada R., Hyon S.-H., Ikada Y. Controlled cisplatin delivery system using ploy (D, L-lactic acid). Biomaterials 1992; 13: 230–234
- Jeffery H., Davis S. S., O'Hara D. T. The preparation and characterization of poly (lactide-co-glycolide) microparticles. II: The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharmaceutical Research 1993; 10: 363–368
- Khang G., Kim S. W., Cho J. C., Rhee J. M., Yoon S. C., Lee H. B. Preparation and characterization of poly (β-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil. Biomedical materials and engineering 2001; 11: 89–103
- Kyo M., Hyon S.-H., Ikada Y. Effects of preparation conditions of cisplatin-loaded microspheres on the in vitro release. Journal of Controlled Release 1995; 35: 73–82
- Lawrence T. S., Maybaum J. Fluoropyrimidines as radiationsensitizers. Seminal Radiation Oncology 1993; 14: 20–28
- Lin Y.-H. E., Vasavada C. Studies on microencapsulation of 5-fluorouracil with poly (ortho ester) polymers. Journal of Microencapsulation 2000; 17: 1–11
- Menei P., Boisdron-Celle M., Croue A., Guy G., Benoit J.-P. Effect of stereotactic implantation of biodegradable 5-fluorouracil loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery 1996; 39: 117–124
- Menei P., Venier M. C., Gamelin E., Saint-Andr´e J.-P., Hayek G., Jadaud E., Fournier D., Mercier P., Guy G., Benoit J.-P. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radio-sensitization of glioblastoma. Cancer 1999; 86: 325–330
- Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactide acid or copoly (lactic/glycolic) acid. Chemical and Pharmaceutical Bulletin 1988a; 36: 1502–1507
- Roullin V.-G., Deverre J.-R., Lemaire L., Hindré F., Venier-Julienne M.-C., Vienet R., Benoit J.-P. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. European Journal of Pharmaceutics and Biopharmaceutics 2002; 53: 293–299
- Rusznyak I., Foldi M., Szabo G. Filtration and absorption through serous membranes. Lymphatics and Lymph Circulation — Physiology and Pathology, 2nd edn, L. Youlten. Pergamon, London 1967; 457–510
- Speyer J. L., Collins J. M., Dedrick R. L., Brennan M. F., Buckpitt A. R., Londer H., Devita V.-T., Myers C.-F. Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Research 1980; 40: 475–510
- Truter E. J., Santos A. S., Els W. J. Assessment of the antitumor activity of targeted immunospecific albumin microspheres loaded with cisplatin and 5-fluorouracil: toxicity against a rodent ovarian carcinoma in vitro. Cell Biology International 2001; 25: 51–59
- Tsutsumi C., Yasuda H. Biodegradation of copolymers composed of optically active L-lactide and (R)- or (S)-methyltrimethylene carbonate. Journal of Polymer Science: Part A: Polymer Chemistry 2001; 39: 3916–3927
- Yan C. H., Resau J. H., Hewetson J., West M., Rill W. L., Kende M. Characterization and morphological analysis of protein-loaded poly (lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. Journal of Controlled Release 1994; 32: 231–241